文献速递烧伤创面修复

自体皮肤细胞悬液在大面积全身体表面积烧伤中的有效性:临床结局与患者费用分析

Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges.
PubMed 文献 · J Burn Care Res · 2024-01-01

单中心回顾性研究(2018-2022年)纳入TBSA≥10%的烧伤患者,比较ASCS±STSG与单纯STSG的结局。ASCS±STSG组住院时间、手术次数、术后并发症和抗生素使用天数分布均显著更优,伤口感染率无差异,每TBSA调整费用分布较低但未达统计学显著。

要点

  • ASCS±STSG组住院时间中位数16.0天,短于STSG组的20.0天(P=.017)。
  • ASCS±STSG组术后并发症11%,低于STSG组的36%(P<.001)。
  • 每TBSA调整费用均值ASCS±STSG组$20,995.0,STSG组$24,882.3,差异未达统计学显著(P=.602)。

核心结论

  • ASCS±STSG较单纯STSG显著缩短住院时间、减少手术次数、降低术后并发症和抗生素使用天数,并可能节省费用。

研究设计与样本

  • 单中心回顾性研究,2018-2022年纳入TBSA≥10%的烧伤患者,分为ASCS±STSG组和单纯STSG组。

主要发现

  • ASCS±STSG组住院时间中位数16.0天(IQR 10-26)vs STSG组20.0天(IQR 14-36),P=.017。
  • ASCS±STSG组手术次数中位数1.0次(IQR 1-2)vs STSG组1.0次(IQR 1-4),P=.020。
  • 术后并发症ASCS±STSG组11% vs STSG组36%,P<.001。
  • 抗生素使用天数分布ASCS±STSG组IQR 0-0(最小-最大0-37)vs STSG组IQR 0-7.0(最小-最大0-76),P=.014。
  • 伤口感染发生率两组无差异(P=.843);每TBSA调整费用分布ASCS±STSG组IQR $10,788.5-$28,332.6 vs STSG组IQR $12,336.8-$29,507.3(P=.602)。

关键数值与推荐

  • ASCS±STSG组住院时间中位数16.0天,STSG组20.0天(P=.017)。
  • ASCS±STSG组术后并发症11%,STSG组36%(P<.001)。
  • 每TBSA调整费用均值ASCS±STSG组$20,995.0,STSG组$24,882.3(P=.602)。

临床怎么用

  • 作者认为ASCS整合于烧伤管理具有实用性,可为患者和医疗机构带来实质性益处。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autologous skin cell suspension (ASCS) is an adjunct to conventional split-thickness skin grafts (STSG) for acute burns, enhancing healing and reducing donor site requirements. This study validates ASCS's predictive benefits in hospital stay reduction and cost savings by analyzing outcomes and real-world charges post-ASCS implementation at a single institution. A retrospective study (2018-2022) included burn patients with ≥10% TBSA. The study population comprised 2 groups: burns treated either with a combination of ASCS ± STSG or with STSG alone. Outcomes included LOS, surgeries, infection, complications, days on antibiotics, and adjusted charge per TBSA. The ASCS ± STSG group demonstrated significantly shorter LOS (Mdn: 16.0 days, IQR: 10-26) than the STSG group (Mdn: 20.0 days, IQR: 14-36; P = .017), and fewer surgeries (Mdn: 1.0, IQR: 1-2) versus the STSG group (Mdn: 1.0, IQR: 1-4; P = .020). Postoperative complications were significantly lower in ASCS ± STSG (11% vs. 36%; P < .001). The STSG group had a longer distribution of antibiotic days (IQR: 0-7.0, min-max: 0-76) than the ASCS ± STSG group (IQR: 0-0, min-max: 0-37; P = .014). Wound infection incidence did not differ (P = .843). ASCS ± STSG showed a lower distribution of adjusted charge per TBSA (IQR: $10 788.5-$28 332.6) compared to the STSG group (IQR: $12 336.8-$29 507.3; P = .602) with a lower mean adjusted charge per TBSA ($20 995.0 vs. $24 882.3), although this was not statistically significant. ASCS ± STSG utilization demonstrated significant reductions in LOS, surgeries, postoperative complications, antibiotics, and potential cost savings. These findings underscore the practicality of integrating ASCS in burn management, offering substantial benefits to patients and healthcare institutions.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Elkady D, Larson BM, Sharma S, et al. Effectiveness of Autologous Skin Cell Suspension in Large Total Body Surface Area Burns: Analysis of Clinical Outcomes and Patient Charges. J Burn Care Res. 2024. PMID: 38943671. doi:10.1093/jbcr/irae133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。